Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Circassia Pharmaceuticals PLC

www.circassia.com

Latest From Circassia Pharmaceuticals PLC

Autolus Faces Life After Woodford With New Czech Backer

PPF has bought a big stake in the UK-based T-cell specialist, one of many firms backed by investor Neil Woodford which have suffered stock slides in the past few months.

United Kingdom Financing

People Round-Up: All Change At UK Agencies As Brexit Looms

The head of the UK’s health technology assessment body NICE is stepping down, while the country’s medicines agency, the MHRA, will have an interim chief in the run-up to the UK’s planned Brexit from the European Union on 31 October.

Appointments Leadership

Keeping Track: Approvals For Mayzent, Mavenclad, Duaklir, Jatenzo And Cimzia

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Regulation

Pacts In Medtech: Circassia, AIT Team Up To Treat Hypertension In Newborns; Otsuka, Click Collaborate On Depression App

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, R&D partnerships and commercial collaborations. This edition covers industry pacts that were sealed in January and February 2019.

Pacts in Medtech Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Immune Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Circassia Holdings Ltd.
  • Circassia Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Circassia Pharmaceuticals PLC
  • Senior Management
  • Steven Harris, CEO
    Julien Cotta, CFO
    Rod Haffner, MD, SVP, R&D
  • Contact Info
  • Circassia Pharmaceuticals PLC
    Phone: (44) 1865 405560
    Robert Robinson Ave, Oxford Science Park
    Northbrook
    Oxford, OX4 4GA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register